Pharmaceutical intermediates industry development history

The development of the pharmaceutical intermediates industry can be traced back to the early 20th century, when pharmaceutical intermediates were mainly produced by API producers themselves or provided by chemical producers. With the continuous development of the pharmaceutical industry, pharmaceutical intermediates gradually became an independent industry and developed rapidly.

In the 1950s and 1960s, with the development and application of new drugs such as antibiotics, anticancer drugs and cardiovascular drugs, the pharmaceutical intermediates industry gained greater development. During this period, many enterprises specializing in the production of pharmaceutical intermediates began to appear and gradually became an important part of the pharmaceutical industry.

In the 1970s and 1980s, with the development of biotechnology and molecular biology and other fields, the pharmaceutical intermediates industry entered a new stage of development. During this period, many new types of pharmaceutical intermediates, such as peptides, proteins and intermediates for gene therapy drugs, began to appear and were widely used.

At the beginning of the 21st century, with the rapid development of the global pharmaceutical industry and the increasing demand of the market, the pharmaceutical intermediates industry has been developed even more. During this period, many pharmaceutical intermediates enterprises began to carry out cross-border mergers and acquisitions to improve their comprehensive strength and market competitiveness. At the same time, the pharmaceutical intermediates industry also began to increase investment in environmental protection and safe production to meet international and domestic laws and regulations.